Hippocampal M1 receptor function associated with spatial learning and memory in aged female rhesus macaques

Age

Volumn 33, Issue 3, 2011, Pages 309-320

  Haley, Gwendolen E ^a,d   Kroenke, Chris ^a,d   Schwartz, Daniel ^b   Kohama, Steven G ^a   Urbanski, Henryk F ^a,c,d   Raber, Jacob ^a,d  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

M1 receptor; Scopolamine phMRI; Spatial maze

Indexed keywords

MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; SCOPOLAMINE;

AGING; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CIRCADIAN RHYTHM; CONTROLLED STUDY; FEMALE; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; LEARNING; MAZE TEST; MENTAL PERFORMANCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; RHESUS MONKEY; SPATIAL MEMORY;

ANIMALS; CIRCADIAN RHYTHM; FEMALE; HIPPOCAMPUS; MACACA MULATTA; MAGNETIC RESONANCE IMAGING; MALE; MAZE LEARNING; MEMORY; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; SPATIAL BEHAVIOR;

EID: 80655125437     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-010-9184-2     Document Type: Article

References (68)

1. Ali-Melkkila T, Kanto J, Iisalo E (1993) Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta Anaesthesiol Scand 37(7):633-642 (Pubitemid 23298996)
2. Araujo JA, Studzinski CM, Milgram NW (2005) Further evidence for the cholinergic hypothesis of aging and dementia from the canine model of aging. Prog Neuropsychopharmacol Biol Psychiatry 29(3):411-422
3. Banta Lavenex P, Lavenex P (2009) Spatial memory and the monkey hippocampus: not all space is created equal. Hippocampus 19(1):8-19
4. Bartholomeusz CF, Wesnes KA, Kulkarni J, Vitetta L, Croft RJ, Nathan PJ (2008) Estradiol treatment and its interaction with the cholinergic system: effects on cognitive function in healthy young women. Horm Behav 54(5):684-693
5. Biggan SL, Ingles JL, Beninger RJ (1996) Scopolamine differentially affects memory of 8-and 16-month-old rats in the double y-maze. Neurobiol Aging 17(1):25-30
6. Cho YH, Friedman E, Silva AJ (1999) Ibotenate lesion of the hippocampus impair spatial learning but not contextual fear conditioning. Behav Brain Res 98:77-87 (Pubitemid 28566198)
7. Costall B, Barnes JM, Hamon M, Muller WE, Briley M (1990) Biochemical models for cognition enhancers. Pharmacop-sychiatry 23(Suppl 2):85-88, discussion 89
8. Day J, Damsma G, Fibiger HC (1991) Cholinergic activity in the rat hippocampus, cortex and striatum correlates with locomotor activity: an in vivo microdialysis study. Pharmacol Biochem Behav 38(4):723-729
9. Dumas JA, Saykin AJ, Mc Donald BC, Mc Allister TW, Hynes ML, Newhouse PA (2008) Nicotinic versus muscarinic blockade alters verbal working memory-related brain activity in older women. Am J Geriatr Psychiatry 16 (4):272-282
10. Ebert U, Kirch W (1998) Scopolamine model of dementia: electroencephalogram findings and cognitive performance. Eur J Clin Investig 28(11):944-949 (Pubitemid 28521587)
11. Ebert U, Grossmann M, Oertel R, Gramatte T, Kirch W (2001) Pharmacokinetic-pharmacodynapic modeling of the elec-troencephalogram effects of scopolamine in healthy volunteers. J Clin Pharmacol 41:51-60
12. Eger EI, Zhang Y, Laster M, Food P, Kendig JJ, Sonner JM (2002) Acetylcholine receptors do not mediate the immo-bilization produced by inhaled anesthetics. Anaesth Analg 94:1500-1504 (Pubitemid 34556632)
13. Elrod K, Buccafusco JJ (1988) An evaluation of the mechanism of scopolamine-induced impairment in two passive avoidance protocols. Pharmacol Biochem Behav 29(1):15-21 (Pubitemid 18052709)
14. Fisher A (2008) Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease. Neurotherapeutics 5(3):433-442 (Pubitemid 351952486)
15. Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I, Brandeis R (2003) M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy. J Mol Neurosci 20(3):349-356 (Pubitemid 38146993)
16. Flynn DD, Ferrari-Di Leo G, Levey AI, Mash DC (1995a) Differential alterations in muscarinic receptor subtypes in alzheimer's disease: implications for cholinergic-based therapies. Life Sci 56(11-12):869-876
17. Flynn DD, Ferrari-Di Leo G, Mash DC, Levey AI (1995b) Differential regulation ofmolecular subtypes ofmuscarinic receptors in Alzheimer's disease. JNeurochem 64(4):1888-1891
18. Fransson P (2004) Spontaneous low-frequency bold signal fluctuations: an f MRI investigation of the resting-state default mode of brain function hypothesis. Hum Brain Mapp 26(1):15-29 (Pubitemid 41232552)
19. Fredrickson A, Snyder PJ, Cromer J, Thomas E, Lewis M, Maruff P (2008) The use ofeffect sizes to characterize the nature of cognitive change in psychopharmacological studies: an example with scopolamine. Hum Psychophar-macol 23(5):425-436
20. Frey KA, Ehrenkaufer RLE, Beaucage S, Agranoff BW (1985) Quantitative in vivo receptor binding: I. Theory and application to the muscarinic cholinergic receptor J Neurosci 5(2):421-428
21. Frey KA, Ciliax B, Agranoff BW (1991) Quantitative in vivo receptor binding: IV. Detection of muscarinic receptor down-regualtion by equilibrium and by tracer kinetic methods. Neurochem Res 16(9):1017-1023
22. Gage FH, Chen KS, Buzsaki G, Armstrong D (1988) Experimental approaches to age-related cognitive impair-ments. Neurobiol Aging 9(5-6):645-655 (Pubitemid 19264159)
23. Gautam D, Duttaroy A, Cui Y, Han SJ, Deng C, Seeger T, Alzheimer C, Wess J (2006) M1-M3 muscarinic acetyl-choline receptor-deficient mice: novel phenotypes. J Mol Neurosci 30(1-2):157-160 (Pubitemid 46035357)
24. Gillette MU, Buchanan GF, Artinian L, Hamilton SE, Nathanson NM, Liu C (2001) Role of the M1 receptor in regulating circadian rhythms. Life Sci 68(22-23):2467-2472 (Pubitemid 32455683)
25. Gold S, Christian B, Arndt S, Zeien G, Cizadlo T, Johnson DL, Flaum M, Andreasen NC (1998) Functional MRI statisti-cal software packages: a comparative analysis. Hum Brain Mapp 6(2):73-84 (Pubitemid 28146507)
26. Haimov I, Hanuka E, Horowitz Y (2008) Chronic insomnia and cognitive functioning among older adults. Behav Sleep Med 6(1):32-54
27. Haley GE, Landauer N, Renner L, Weiss A, Hooper K, Urbanski HF, Kohama SG, Neuringer M, Raber J (2009) Circadian activity associated with spatial learning and memory in aging rhesus monkeys. Exp Neurol217(1):55-62
28. Hartikainen K, Rorarius M (1999) Cortical responses to auditory stiuli during isoflurane burst suppression. Anaes-thesia 54:210-214 (Pubitemid 29126969)
29. Jagoda EM, Kiesewetter DO, Shimoji K, Ravasi L, Yamada M, Gomeza J, Wess J, Eckelman WC (2003) Regional brain uptake of the muscarinic ligand, [18f]fp-tztp, is greatly decreased in M2 receptor knockout mice but not in M1, M3 and M4 receptor knockout mice. Neuropharmacology 44(5):653-661 (Pubitemid 36372054)
30. Klinkenberg I, Blokland A(2010) The validity ofscopolamine as a pharmacological model for cognitive impairment: a review of animal behavioral studies. Neurosci Biobehav Rev (in press)
31. Knutson B, Gibbs SE (2007) Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology (Berl) 191(3):813-822 (Pubitemid 46355904)
32. Lavenex PB, Amaral DG, Lavenex P (2006) Hippocampal lesion prevents spatial relational learning in adult macaque monkeys. J Neurosci 26(17):4546-4558 (Pubitemid 44315354)
33. Liu C, Gillette MU (1996) Cholinergic regulation of the suprachiasmatic nucleus circadian rhythm via a muscarinic mechanism at night. J Neurosci 16(2):744-751 (Pubitemid 26028833)
34. Logothetis NK, Guggenberger H, Peled S, Pauls J (1999) Functional imaging of the monkey brain. Nat Neurosci 2 (6):555-562 (Pubitemid 30491237)
35. Luan L, Ding F, Ai Y, Andersen A, Hardy P, Forman E, Gerhardt GA, Gash DM, Grondin R, Zhang Z (2008) Pharmacological MRI (ph MRI) monitoring of treatment in hemiparkinsonian rhesus monkeys. Cell Transplant 17(4):417-425
36. Ma L, Seager MA, Wittmann M, Jacobson M, Bickel D, Burno M, Jones K, Graufelds VK, Xu G, Pearson M, Mc Campbell A, Gaspar R, Shughrue P, Danziger A, Regan C, Flick R Pascarella D, Garson S, Doran S, Kreatsoulas C, Veng L, Lindsley CW, Shipe W, Kuduk S, Sur C, Kinney G, Seabrook GR, Ray WJ (2009) Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation. Proc Natl Acad Sci USA 106(37):15950-15955
37. Matsui M, Yamada S, Oki T, Manabe T, Taketo MM, Ehlert FJ (2004) Functional analysis of muscarinic acetylcholine receptors using knockout mice. Life Sci 75(25):2971-2981 (Pubitemid 39330580)
38. Morin CM, Blais FC, Mimeault V (1998) Sleep disturbances in late life. In: Hersen M, Van Hasselt VB (eds) Handbook of clinical geropsychology Plenum, New York, pp 273-299
39. Murrell JC, Waters D, Johnson CB (2008) Comparative effects ofhalothane, isoflurane, sevoflurane, and desflurane on the electroencephalogram of the rat Lab Anim 42:161-170 (Pubitemid 351786019)
40. Nakayama T, Penheiter AR, Penheiter SG, Chini EN, Thompson M, Warner DO, Jones KA (2006) Differential effects of volatile anesthetics on M3 muscarinic receptor coupling to the gθq heterotrimeric g protein. Anesthesiology 105:313-324 (Pubitemid 44148176)
41. Nathanson NM (2008) Synthesis, trafficking, and localization ofmuscarinic acetylcholine receptors. Pharmacol Ther 119 (1):33-43
42. Ogawa T, Shingu K, Shibata M, Osawa M, Mori K (1992) The divergent actions of volatile anaesthetics on background neuronal activity and reactive capability in the central nervous system in cats. Can J Anaesth 39:862-872
43. Pereira FR, Alessio A, Sercheli MS, Pedro T, Bilevicius E, Rondina JM, Ozelo HF, Castellano G, Covolan RJ, Damasceno BP, Cendes F (2010) Asymmetrical hippo-campal connectivity in mesial temporal lobe epilepsy: evidence from resting state f MRI. BMC Neurosci 11:66
44. Porkkala T, Kaukinen S, Hakkinen V, Jantti V (1997) Median nerve somatosenory evoked potentials during isoflurane anaesthesia. Can J Anaesth 44:963-968 (Pubitemid 28022618)
45. Qiu A, Tuan TA, Woon PS, Abdul-Rahman MF, Graham S, Sim K (2010) Hippocampal-cortical structural connectivity disruptions in schizophrenia: an integrated perspective from hippocampal shape, cortical thickness, and integrity of white matter bundles. Neuro Image (in press)
46. Raber J, Rola R, Le Fevour A, Morhardt D, Curley J, Mizumatsu S, Vanden Berg SR, Fike JR (2004) Radiation-induced cognitive impairments are associated with changes in indicators of hippocampalneurogenesis. Radiat Res 162:39-47 (Pubitemid 39044717)
47. Rosier A, Cornette L, Orban GA (1998) Scopolamine-induced impairment of delayed recognition of abstract visual shapes. Neuropsychobiology 37(2):98-103 (Pubitemid 28143025)
48. Rouse ST, Edmunds SM, Yi H, Gilmor ML, Levey AI (2000) Localization of m(2) muscarinic acetylcholine receptor protein in cholinergic and non-cholinergic terminals in rat hippocampus. Neurosci Lett 284(3):182-186 (Pubitemid 30204543)
49. Sarter M, Turchi J (2002) Age-and dementia-associated impairments in divided attention: psychological con-structs, animal models, and underlying neuronal mecha-nisms. Dement Geriatr Cogn Disord 13(1):46-58 (Pubitemid 33153188)
50. Savage UC, Faust WB, Lambert P, Moerschbaecher JM (1996) Effects of scopolamine on learning and memory in monkeys. Psychopharmacology (Berl) 123(1):9-14 (Pubitemid 26040248)
51. Scali C, Vannucchi MG, Pepeu G, Casamenti F (1995) Peripherally injected scopolamine differentially modulates acetylcholine release in vivo in the young and aged rats. Neurosci Lett 197(3):171-174
52. Small SA, Chawla MK, Buonocore M, Rapp PR, Barnes CA (2004) Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc Natl Acad Sci USA 101 (18):7181-7186 (Pubitemid 38596463)
53. Taffe MA, Weed MR, Gold LH (1999) Scopolamine alters rhesus monkey performance on a novel neuropsychological test battery. Brain Res Cogn Brain Res 8(3):203-212 (Pubitemid 29518307)
54. Tamminga CA (2006) The neurobiology of cognition in schizophrenia. J Clin Psychiatry 67(9):e1 1
55. Thathiah A, De Strooper B (2009) G protein-coupled receptors, cholinergic dysfunction, and A beta toxicity in Alzheimer's disease. Sci Signal 2(93):re8
56. Thiel CM (2003) Cholinergic modulation of learning and memory in the human brain as detected with functional neuroimaging. Neurobiol Learn Mem 80:234-244 (Pubitemid 37159351)
57. Thomas E, Snyder PJ, Pietrzak RH, Jackson CE, Bednar M, Maruff P (2008) Specific impairments in visuospatial working and short-term memory following low-dose scopolamine challenge in healthy older adults. Neuro-psychologia 46(10):2476-2484
58. Tinkler GP, Voytko ML (2005) Estrogen modulates cognitive and cholinergic processes in surgically menopausal monkeys. Prog Neuropsychopharmacol Biol Psychiatry 29(3):423-431 (Pubitemid 40417594)
59. Tsushima K, Shingu K, Ikeda S, Kimura H, Yamada K, Murao K (1998) Supressive actions ofvolatile anaesthetics on the response capability in cats. Can J Anaesth 45:240-245 (Pubitemid 28253017)
60. Van Kampen JM, Eckman CB (2009) Agonist-induced resto-ration of hippocampal neurogenesis and cognitive im-provement in a model of cholinergic denervation. Neuropharmacology (in press)
61. Vannucchi MG, Goldman-Rakic PS (1991) Age-dependent decrease in the affinity of muscarinic M1 receptors in neocortex of rhesus monkeys. Proc Natl Acad Sci USA 88 (24):11475-11479 (Pubitemid 21916064)
62. Vincent JL, Patel GH, Fox MD, Snyder AZ, Baker JT, Van Esen DC, Zempel JM, Snyder LH, Corbetta M, Raichle ME (2007) Intrinsic functional architecture in the anaesthetized monkey brain. Nature 447:83-86 (Pubitemid 46685840)
63. Wagster MV, Whitehouse PJ, Walker LC, Kellar KJ, Price DL (1990) Laminar organization and age-related loss of cholinergic receptors in temporal neocortex of rhesus monkey. J Neurosci 10(9):2879-2885
64. Wamsley JK, Zarbin MA, Birdsall NJM, Kuhar MJ (1980) Muscarinic cholinergic receptors: autoradiographic locali-zation ofhigh and low affinity agonist binding sites. Brain Res 200:1-12 (Pubitemid 10061587)
65. Wink AM, Bernard F, Salvador R, Bullmore E, Suckling J (2006) Age and cholinergic effects on hemodynamics and functional coherence of human hippocampus. Neurobiol Aging 27:1395-1404 (Pubitemid 44313873)
66. Wise RG, Tracey I (2006) The role of f MRI in drug discovery. J Magn Reson Imaging 23(6):862-876
67. Wisman LA, Sahin G, Maingay M, Leanza G, Kirik D (2008) Functional convergence of dopaminergic and cholinergic input is critical for hippocampus-dependent working memory. J Neurosci 28(31):7797-7807
68. Zhang Z, Andersen AH, Ai Y, Loveland A, Hardy PA, Gerhardt GA, Gash DM (2006) Assessing nigrostriatal dysfunctions by pharmacological MRI in Parkinsonian rhesus maca-ques. Neuroimage 33(2):636-643 (Pubitemid 44485558)